Ensign Peak Advisors Inc cut its stake in Cardinal Health, Inc. (NYSE:CAH - Free Report) by 29.0% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The firm owned 111,058 shares of the company's stock after selling 45,395 shares during the period. Ensign Peak Advisors Inc's holdings in Cardinal Health were worth $13,135,000 at the end of the most recent reporting period.
Several other large investors have also bought and sold shares of the company. Cyrus J. Lawrence LLC purchased a new stake in shares of Cardinal Health in the fourth quarter worth $26,000. Promus Capital LLC purchased a new stake in Cardinal Health during the 4th quarter valued at about $30,000. Bellwether Advisors LLC bought a new stake in Cardinal Health during the 4th quarter valued at about $32,000. Lee Danner & Bass Inc. purchased a new position in Cardinal Health in the fourth quarter worth about $35,000. Finally, Itau Unibanco Holding S.A. bought a new position in shares of Cardinal Health in the fourth quarter worth approximately $36,000. 87.17% of the stock is owned by institutional investors.
Wall Street Analyst Weigh In
A number of equities analysts recently weighed in on the stock. Mizuho boosted their price objective on shares of Cardinal Health from $142.00 to $150.00 and gave the stock an "outperform" rating in a report on Monday, March 31st. Argus set a $148.00 price target on Cardinal Health in a research note on Tuesday, February 4th. Citigroup reaffirmed a "neutral" rating on shares of Cardinal Health in a report on Thursday, May 1st. JPMorgan Chase & Co. boosted their target price on Cardinal Health from $142.00 to $145.00 and gave the stock a "neutral" rating in a research report on Tuesday, February 4th. Finally, Jefferies Financial Group upgraded shares of Cardinal Health from a "hold" rating to a "buy" rating and upped their target price for the company from $140.00 to $150.00 in a research note on Wednesday, February 5th. Four research analysts have rated the stock with a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the stock. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $146.43.
Check Out Our Latest Analysis on CAH
Cardinal Health Stock Performance
Shares of Cardinal Health stock traded up $3.29 during trading hours on Thursday, hitting $151.70. The company's stock had a trading volume of 1,948,092 shares, compared to its average volume of 2,224,226. The company has a market cap of $36.21 billion, a PE ratio of 28.30, a PEG ratio of 1.49 and a beta of 0.66. The business has a 50 day moving average price of $135.94 and a two-hundred day moving average price of $127.06. Cardinal Health, Inc. has a 12-month low of $93.17 and a 12-month high of $154.07.
Cardinal Health (NYSE:CAH - Get Free Report) last posted its earnings results on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, beating analysts' consensus estimates of $2.15 by $0.20. The firm had revenue of $54.88 billion during the quarter, compared to analyst estimates of $55.33 billion. Cardinal Health had a net margin of 0.59% and a negative return on equity of 59.57%. Cardinal Health's revenue for the quarter was up .0% compared to the same quarter last year. During the same period last year, the firm posted $2.08 earnings per share. As a group, research analysts anticipate that Cardinal Health, Inc. will post 7.95 earnings per share for the current year.
Cardinal Health Increases Dividend
The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 15th. Investors of record on Tuesday, July 1st will be given a $0.5107 dividend. The ex-dividend date is Tuesday, July 1st. This represents a $2.04 annualized dividend and a yield of 1.35%. This is a positive change from Cardinal Health's previous quarterly dividend of $0.51. Cardinal Health's dividend payout ratio (DPR) is currently 31.83%.
Cardinal Health Profile
(
Free Report)
Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.
Featured Articles
Before you consider Cardinal Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Cardinal Health wasn't on the list.
While Cardinal Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
